Peer review reports
From: Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
Original Submission | ||
---|---|---|
13 Sep 2022 | Submitted | Original manuscript |
30 Sep 2022 | Reviewed | Reviewer Report - Eleonora De Matteis |
2 Oct 2022 | Reviewed | Reviewer Report - Antonio Russo |
11 Oct 2022 | Reviewed | Reviewer Report |
18 Oct 2022 | Author responded | Author comments - Uwe Reuter |
Resubmission - Version 2 | ||
18 Oct 2022 | Submitted | Manuscript version 2 |
Publishing | ||
19 Oct 2022 | Editorially accepted | |
15 Nov 2022 | Article published | 10.1186/s10194-022-01511-y |